Legacy Advisors, LLC Abb Vie Inc. Transaction History

Legacy Advisors, LLC

$978 Million
Q4 2024

A detailed history of Legacy Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Legacy Advisors, LLC holds 20,812 shares of ABBV stock, worth $4.21 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

20,812

Previous 21,897 4.96%

Holding current value

$4.21 Million

Previous $4.32 Million 14.48%

% of portfolio

0.38%

Previous 0.47%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$164.99 - $203.87 $179,014 - $221,198	-1,085 Reduced 4.96%	20,812 $3.7 Million
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $331,776 - $403,643	2,025 Added 10.19%	21,897 $4.32 Million
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $8,049 - $9,399	52 Added 0.26%	19,872 $3.41 Million
Q1 2024 Apr 30, 2024	BUY	$159.82 - $182.1 $122,901 - $140,034	769 Added 4.04%	19,820 $3.61 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $241,212 - $271,662	-1,753 Reduced 8.43%	19,051 $2.95 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $451,801 - $523,026	3,382 Added 19.41%	20,804 $3.1 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $1.62 Million - $2.02 Million	12,244 Added 236.46%	17,422 $2.35 Million
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $26,608 - $30,643	184 Added 3.68%	5,178 $825,000
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $29,598 - $35,496	214 Added 4.48%	4,994 $807,000
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $37,310 - $42,792	-278 Reduced 5.5%	4,780 $642,000
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $37,295 - $47,414	271 Added 5.66%	5,058 $775,000
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $371,919 - $461,447	2,818 Added 143.12%	4,787 $776,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $20,948 - $26,506	-195 Reduced 9.01%	1,969 $267,000
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $21,918 - $24,880	206 Added 10.52%	2,164 $233,000
Q1 2021 Apr 12, 2021	BUY	$102.3 - $112.62 $200,303 - $220,509	1,958 New	1,958 $212,000
Q3 2019 Oct 10, 2019	SELL	$62.98 - $75.72 $64,806 - $77,915	-1,029 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$65.7 - $83.98 $1,773 - $2,267	-27 Reduced 2.56%	1,029 $75,000
Q1 2019 Apr 08, 2019	BUY	$77.14 - $90.79 $81,459 - $95,874	1,056 New	1,056 $85,000
Q4 2018 Jan 14, 2019	SELL	$77.85 - $96.01 $180,767 - $222,935	-2,322 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$88.91 - $98.84 $138,077 - $153,498	1,553 Added 201.95%	2,322 $220,000
Q2 2018 Jul 19, 2018	BUY	$89.78 - $106.23 $48,660 - $57,576	542 Added 238.77%	769 $71,000
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $7,164 - $7,856	80 Added 54.42%	227 $21,000
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $10,267 - $13,115	147	147 $13,000

Others Institutions Holding ABBV

# of Institutions

4,095

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.

Account

Legacy Advisors, LLC Abb Vie Inc. Transaction History